The 88th China International Pharmaceutical Active Pharmaceutical Ingredients (API) / Intermediates / Packaging / Equipment Exhibition (API China Exhibition) and the 26th China International Pharmaceutical (Industrial) Exhibition and Technical Exchange (CHINA-PHARM Exhibition) will be held at the Qingdao World Expo City in the West Coast New Area of Qingdao from April 12th to 14th, 2023. This exhibition aims to further connect the entire pharmaceutical industry chain and stimulate pharmaceutical innovation.
As the first professional exhibition in the Chinese pharmaceutical industry in 2023, this exhibition has the theme of “Innovation and Cooperation.” It collaborates with various pharmaceutical industry associations and organizations such as the China Chemical Pharmaceutical Industry Association, China Pharmaceutical Packaging Association, and International Pharmaceutical Excipients Association. It also collaborates with over 1,200 pharmaceutical API, intermediates, pharmaceutical excipients, pharmaceutical packaging, and pharmaceutical equipment companies, as well as more than 4,000 pharmaceutical production enterprises and nearly 60,000 professionals in the pharmaceutical industry nationwide. The exhibition aims to anchor the overall goal of high-quality development in China’s pharmaceutical industry, promote industry upgrade through innovation, and shape new advantages in the development of the Chinese pharmaceutical industry, creating a resilient, high-safety, and constantly expanding industry chain.
According to the latest data, China’s contribution to the global pharmaceutical R&D pipeline has increased from 4% in 2015 to 20% in 2022. The Chinese pharmaceutical market accounts for 20.3% of the global pharmaceutical market. In 2022, the operating income of China’s pharmaceutical manufacturing industry reached 4.2 trillion yuan (including 2.9 trillion yuan for pharmaceuticals and 1.3 trillion yuan for medical devices), making China an important contributor to the growth of the global pharmaceutical market.
In light of these developments, the API China Exhibition focuses on serving the fields of pharmaceutical research and production, providing a platform for the display and technical exchange of products throughout the entire industry chain and the entire lifecycle for pharmaceuticals and health nutrition products. API China has become the preferred platform for excellent pharmaceutical companies in China and the Asia-Pacific region for purchasing products, exchanging technologies, obtaining industry information, and establishing and maintaining industry connections.
The API China Exhibition and CHINA-PHARM Exhibition integrate industry needs, promote industry upgrades and market changes through innovation and cooperation. They continue to build a platform that serves the entire industry, promotes industry exchanges and trade cooperation. Over 1,200 pharmaceutical API, intermediates, pharmaceutical excipients, pharmaceutical packaging, and pharmaceutical equipment companies from across the country will gather in the West Coast New Area of Qingdao to showcase the latest technologies and products in the global pharmaceutical research, development, and production fields to tens of thousands of pharmaceutical professionals from home and abroad.